Abbott Laboratories (ABT)
107.30
+2.03
(+1.93%)
USD |
NYSE |
Apr 19, 16:00
107.29
-0.01
(-0.01%)
After-Hours: 20:00
Abbott Laboratories Free Cash Flow (Quarterly): 2.283B for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.283B |
| September 30, 2023 | 1.317B |
| June 30, 2023 | 696.00M |
| March 31, 2023 | 763.00M |
| December 31, 2022 | 1.716B |
| September 30, 2022 | 2.313B |
| June 30, 2022 | 2.031B |
| March 31, 2022 | 1.744B |
| December 31, 2021 | 2.453B |
| September 30, 2021 | 2.24B |
| June 30, 2021 | 1.715B |
| March 31, 2021 | 2.24B |
| December 31, 2020 | 3.119B |
| September 30, 2020 | 1.57B |
| June 30, 2020 | 680.00M |
| March 31, 2020 | 355.00M |
| December 31, 2019 | 1.982B |
| September 30, 2019 | 1.547B |
| June 30, 2019 | 592.00M |
| March 31, 2019 | 377.00M |
| December 31, 2018 | 1.298B |
| September 30, 2018 | 1.829B |
| June 30, 2018 | 946.00M |
| March 31, 2018 | 833.00M |
| December 31, 2017 | 1.295B |
| Date | Value |
|---|---|
| September 30, 2017 | 1.742B |
| June 30, 2017 | 1.096B |
| March 31, 2017 | 302.00M |
| December 31, 2016 | 851.00M |
| September 30, 2016 | 905.00M |
| June 30, 2016 | 662.00M |
| March 31, 2016 | -336.00M |
| December 31, 2015 | 580.00M |
| September 30, 2015 | 784.00M |
| June 30, 2015 | 725.00M |
| March 31, 2015 | -233.00M |
| December 31, 2014 | 951.00M |
| September 30, 2014 | 924.00M |
| June 30, 2014 | 642.00M |
| March 31, 2014 | 81.00M |
| December 31, 2013 | 1.322B |
| September 30, 2013 | 245.00M |
| June 30, 2013 | 426.00M |
| March 31, 2013 | 186.00M |
| December 31, 2012 | 1.117B |
| September 30, 2012 | 2.989B |
| June 30, 2012 | 1.642B |
| March 31, 2012 | 1.772B |
| December 31, 2011 | 1.127B |
| September 30, 2011 | 2.602B |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
355.00M
Minimum
Mar 2020
3.119B
Maximum
Dec 2020
1.650B
Average
1.716B
Median
Dec 2022
Free Cash Flow (Quarterly) Benchmarks
| Stryker Corp | 1.383B |
| Boston Scientific Corp | 690.00M |
| Edwards Lifesciences Corp | 35.00M |
| Insulet Corp | 13.60M |
| Intuitive Surgical Inc | -207.20M |